Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,957 | -14,026 | -8,445 | -4,381 | -59,082 |
| Depreciation Amortization | 20 | 20 | 15 | 9 | 259 |
| Income taxes - deferred | -203 | -203 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,416 | -1,079 | -563 | -329 | -2,206 |
| Other Working Capital | -2,128 | -933 | -676 | -1,294 | -6,169 |
| Other Operating Activity | 10,539 | 6,415 | 2,161 | 1,204 | 22,350 |
| Operating Cash Flow | $-12,145 | $-9,806 | $-7,508 | $-4,791 | $-44,848 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 27,352 |
| PPE Investments | 4 | 4 | N/A | N/A | -59 |
| Net Acquisitions | -50 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-46 | $4 | $N/A | $N/A | $27,293 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,223 | N/A | N/A | N/A | 31,496 |
| Financing Cash Flow | $2,223 | $N/A | $N/A | $N/A | $31,496 |
| Beginning Cash Position | 18,257 | 18,257 | 18,257 | 18,257 | 4,316 |
| End Cash Position | 8,289 | 8,455 | 10,749 | 13,466 | 18,257 |
| Net Cash Flow | $-9,968 | $-9,802 | $-7,508 | $-4,791 | $13,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,145 | -9,806 | -7,508 | -4,791 | -44,848 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -59 |
| Free Cash Flow | -12,145 | -9,806 | -7,508 | -4,791 | -44,907 |